1. Asai, F. and Schrör, K. (1987) ‘Different effects of thromboxane synthetase inhibition on PGI2 and PGE2 synthesis in human vascular tissue bathed in clotting blood’, in H. Sinzinger and K. Schrör (eds.), Prostaglandins in Clinical Research, Alan R. Liss Inc., New York, pp. 259–264.
2. Ashton, J., Schmitz, J., Campbell, W., Ogletree, M., Raheja, S., Taylor, A., FitzGerald, C., Buja, L., and Willerson, J.T. (1986) ‘Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists’, Circ. Res. 59, 568–578.
3. Bertele, G., Mussoni, V., Pintucci, G., del Rosso, G., Romano, C., de Gaetano, G., and Libretti, A. (1989) ‘The inhibitory effect of aspirin on fibrinolysis is reversed by iloprost, a prostacyclin-analogue, Thromb. Haemostasis 61, 286–288.
4. Braun, M. and Schrör, K. (1990) ‘Bay U 3405 inhibits cerebral vasospasm induced by authentic thromboxane A2’, Stroke 21 (Suppl IV), 152–154.
5. Brewster, A. G., Braun, G. R., Jessup, R., Smithers, M. N. J., and Stocker, A. (1990) ‘1,3-dioxane derivatives possessing potent thromboxane A2 receptor antagonism and thromboxane A2 synthase inhibition’, Proc. 7th Intern. Conf. Prostagl., p.178